Kenya to Expand HIV Prevention with New Biannual Injection

Kenya’s health authorities are preparing to roll out a new long-acting injectable medication aimed at preventing HIV infections, starting in early March 2026. The initiative represents a major step in expanding prevention options beyond daily oral medication.

The program will initially target 15 counties identified as having the highest HIV burdens. Health officials say the twice-yearly injection, Lenacapavir, will make it easier for at-risk individuals to adhere to prevention routines compared with taking daily pills.

The rollout is part of Kenya’s broader strategy to reduce new HIV infections, especially among young people and vulnerable groups. Officials hope the program will encourage more consistent use of preventive treatments across the country.

Additional doses are expected in the coming months to support wider coverage and ensure a steady supply for those enrolled in the program. The government plans to gradually expand access nationwide as the program progresses.